JohnDScandlingJr.MD

Nephrology • Palo Alto, CA

Professor, Medicine - Nephrology, Stanford University Medical Center

Join to view full profile

Dr. Scandling is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Scandling's full profile

Already have an account?

Office
300 Pasteur Dr
Palo Alto, CA 94305
Phone+1 650-725-9891

Education & Training

University of RochesterFellowship, Nephrology, 1981 - 1982
West Virginia UniversityResidency, Internal Medicine, 1978 - 1981
Virginia Commonwealth University School of MedicineClass of 1978

Certifications & Licensure

CA State Medical License 1989 - 2026
NV State Medical License 2019 - 2025
VA State Medical License 1984 - 2002
NY State Medical License 1981 - 1997
WV State Medical License 1979 - 1995
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) Start of enrollment: 2005 Jun 01
Completed
Phase 4
Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs Start of enrollment: 2004 Jul 01
Active, not recruiting
Phase 1, Phase 2
Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs. Start of enrollment: 2010 Jul 14
Active, not recruiting
Phase 1

Publications & Presentations

PubMed

35 citations
Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation.
Colin R. Lenihan, Maria E. Montez-Rath, John D. Scandling, Mintu P. Turakhia, Wolfgang C. Winkelmayer
American Journal of Transplantation. 2013-06-01
12 citations
Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017.
Xingxing S Cheng, Jialin Han, Jennifer L Braggs-Gresham, Philip J Held, Stephan Busque
JAMA Network Open. 2022-03-01
9 citations
A new approach to kidney wait-list management in the kidney allocation system era: Pilot implementation and evaluation.
Xingxing S. Cheng, Stephan Busque, Jenny Lee, Kevin V. Discipulo, Christine Hartley
Clinical Transplantation. 2018-11-01

Journal Articles

Review Macrochimerism and Clinical Transplant Tolerance
Samuel Strober, Stephan Busque, Edgar Engleman, Robert Lowsky, John D Scandling, Judith Shizuru, ScienceDirect

Press Mentions

Stanford Team Prevents Kidney Transplant Rejection Without DrugsApril 24th, 2002

Grant Support

Cyclosporine &Neoral In Post Renal Allograft RecipientsNational Center For Research Resources1999–2001